Cargando…

Single-Cell RNA-Seq Identifies Pathways and Genes Contributing to the Hyperandrogenemia Associated with Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by hyperandrogenemia of ovarian thecal cell origin, resulting in anovulation/oligo-ovulation and infertility. Our previous studies established that ovarian theca cells isolated and propagated from ovaries of normal ovulato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harris, R. Alan, McAllister, Jan M., Strauss, Jerome F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341507/ https://www.ncbi.nlm.nih.gov/pubmed/37445796 http://dx.doi.org/10.3390/ijms241310611

Ejemplares similares

Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
por: López-Alarcón, Mardia, et al.
Publicado: (2023)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary Syndrome
por: Abdalqader, Manal Madany, et al.
Publicado: (2020)

Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
por: O'Reilly, Michael W., et al.
Publicado: (2014)

Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype
por: Lerchbaum, Elisabeth, et al.
Publicado: (2014)

Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome
por: Kara, Ozlem, et al.
Publicado: (2023)

Colocalization of Polycystic Ovary Syndrome Candidate Gene Products in Theca Cells Suggests Novel Signaling Pathways
por: Kulkarni, Rewa, et al.
Publicado: (2019)

Embryos from polycystic ovary syndrome patients with hyperandrogenemia reach morula stage faster than controls
por: Chappell, Neil Ryan, et al.
Publicado: (2020)

OR15-3 Contribution of Hyperandrogenemia to Dysbiosis, Gut Inflammation, and Dysregulation of Short-Chain Fatty Acid Homeostasis in Mouse Model of Polycystic Ovary Syndrome
por: Alsemeh, Amira, et al.
Publicado: (2022)

Low Serum 25-Hydroxyvitamin D Levels Are Associated With Hyperandrogenemia in Polycystic Ovary Syndrome: A Cross-Sectional Study
por: Shan, Chang, et al.
Publicado: (2022)

Cholesterol Side-Chain Cleavage Gene Expression in Theca Cells: Augmented Transcriptional Regulation and mRNA Stability in Polycystic Ovary Syndrome
por: Wickenheisser, Jessica K., et al.
Publicado: (2012)

A Review of Special Considerations on Insulin Resistance Induced Hyperandrogenemia in Women with Polycystic Ovary Syndrome: A Prominent COVID-19 Risk Factor
por: Roozbeh, Jamshid, et al.
Publicado: (2022)

A new evidence‐based guideline for assessment and management of polycystic ovary syndrome
por: Rodgers, Raymond J, et al.
Publicado: (2019)

Diagnosis of Sertoli-Leydig Cell Tumor of the Ovary Complicated by the Pattern of Hyperandrogenemia and Results of Imaging
por: Jaju, Amruta, et al.
Publicado: (2021)

Sensitive and specific markers for insulin resistance, hyperandrogenemia, and inappropriate gonadotrophin secretion in women with polycystic ovary syndrome: a case-control study from Bahrain
por: Golbahar, Jamal, et al.
Publicado: (2012)

Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia—A New Insight on Syndrome Pathogenesis
por: Ozegowska, Katarzyna, et al.
Publicado: (2020)

Adrenal myelolipoma with hyperandrogenemia and schizophrenia
por: Liu, Ningning, et al.
Publicado: (2018)

Postmenopausal mild hirsutism and hyperandrogenemia due to granulosa cell tumor of the ovary: a case report
por: Adefris, Mulat, et al.
Publicado: (2017)

Hyperandrogenemia due to ingestion of Butea superba
por: Chaiyasit, Kamon, et al.
Publicado: (2012)

The impact of obesity on hyperandrogenemia in Korean girls
por: Kang, Min Jae, et al.
Publicado: (2016)

Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome
por: YETİM ŞAHİN, Aylin, et al.
Publicado: (2019)

Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue
por: Zhang, Yahui, et al.
Publicado: (2023)

Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology
por: Dadachanji, Roshan, et al.
Publicado: (2018)

Postmenopausal women with hyperandrogenemia: Three case reports
por: Zhu, Xiao-Dan, et al.
Publicado: (2021)

Cardiometabolic consequences of maternal hyperandrogenemia in male offspring
por: Zuchowski, Yvonne, et al.
Publicado: (2021)

Statistical Genomic Approach Identifies Association between FSHR Polymorphisms and Polycystic Ovary Morphology in Women with Polycystic Ovary Syndrome
por: Du, Tao, et al.
Publicado: (2015)

Harnessing Expression Data to Identify Novel Candidate Genes in Polycystic Ovary Syndrome
por: Jones, Michelle R., et al.
Publicado: (2011)

Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life?
por: Hartanti, Monica D., et al.
Publicado: (2020)

The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women
por: Valderhaug, T.G., et al.
Publicado: (2015)

Identifying genes associated with the development of human polycystic ovary syndrome
por: Saddick, Salina Y.
Publicado: (2020)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Lifestyle and environmental contributions to ovulatory dysfunction in women of polycystic ovary syndrome
por: Zhang, Bingqian, et al.
Publicado: (2020)

Lipid Profile in Adolescent Girls with Type 1 Diabetes Mellitus and Hyperandrogenemia
por: Zachurzok, Agnieszka, et al.
Publicado: (2016)

Testosterone/Epitestosterone Ratios—Further Hints to Explain Hyperandrogenemia in Children with Autism
por: Gasser, Benedikt, et al.
Publicado: (2021)

THU650 Prevalence Of Hyperandrogenemia, PCOS And Obesity In Mothers Of Daughters With PCOS
por: Cai, Jie, et al.
Publicado: (2023)

Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
por: Wang, Kexin, et al.
Publicado: (2023)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4gchuns03juqat3fhtgkokp6kk